Carterra® is a leading provider of innovative technologies designed to accelerate the discovery of novel therapeutic candidates. Carterra’s high throughput screening and characterization technology combines patented microfluidics with real-time High Throughput Surface Plasmon Resonance (HT-SPR) instruments, consumables, and industry-leading Kinetic and Epitope Analysis and Visualization Software™, delivering up to 100 times the throughput in 10% of the time while using only 1% of the sample compared to existing platforms.
Read about Carterra in the news:
- ENPICOM and Carterra Advance Antibody Screening by Integrating Biophysical Characterization and Repertoire Sequencing Analysis
- Icosagen Acquires the Carterra LSA Instrument to Significantly Enhance Its Antibody Screening Capabilities in the Discovery and Development of New Therapeutic and Diagnostic Antibodies
- Carterra expands best-in-class franchise with the launch of the LSAXT high-throughput SPR biosensor at SLAS 2023
- More News